Discusses Modulation and Combination Strategies in ER-Positive Metastatic Breast Cancer and the Role of Lasofoxifene April 29, ...

Pre-randomization Atrioventricular Interval Modulation Therapy (“AVIM Therapy”) set-up data from the MODERATO II randomized, prospective, ...

Oral MYC condensate modulator drives tumor regression and stasis in preclinical modelsDisruption of MYC condensates enables targeted inhibition ...

Biomea Fusion (NASDAQ:BMEA) executives highlighted early, exploratory clinical data for icovamenib in type 1 diabetes, presenting top-line results from the company’s COVALENT-112 proof-of-concept ...

Data highlight biomarker-linked activity and in vivo efficacy of STX-6398, supporting small-molecule CKAP2 modulation as a ...

Oral presentations highlight first-in-human data for TRX103 and novel CAR-Tr1 Treg therapy TRX319. Data underscore potential ...

Researchers reported favorable safety and tolerability for CS1 after 12 months of treatment in patients with pulmonary arterial hypertension.

Three posters accepted at AACR 2026 highlighting SK Life Science Labs' targeted protein degradation pipeline -- Programs featured: selective p300 and PRMT5 degraders -- p300 degrader data demonstrate: ...

Sensory processing is fundamental to perception, action, and cognition, and its disruption contributes to a wide range of neurological, psychiatric, and ...

Marks First In-Human Clinical Study Demonstrating the Value of Immuno-Pharmacodynamics in the Assessment of Radioligand Therapy -- Novigenix AI Liquid Biopsy Platform Identifies Immune Activation ...

The Phase II trial enrolled 129 participants, of whom 94% had relapsing remitting multiple sclerosis, and 6% had secondary ...

Oral presentation will highlight new interim clinical data from the ongoing POLARIS studies; additional posters showcase broader platform capabilities -SOUTH SAN FRANCISCO, Calif.--(BUSINESS ...